TY - CONF T1 - SCHIZOPHRENIA TREATMENT WITH SECOND-GENERATION ANTIPSYCHOTICS: A MULTI-COUNTRY EVALUATION OF THE COSTS OF CARDIOVASCULAR AND METABOLIC ADVERSE EVENTS AND WEIGHT GAIN JO - VALUE IN HEALTH PY - 2020/01/01 AU - Kearns B AU - Cooper K AU - Cantrell A ED - VL - 23 SP - S605 EP - S605 Y2 - 2024/09/20 ER -